SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BERNARDI, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 36.560
AS - Asia 19.878
EU - Europa 12.373
SA - Sud America 3.017
AF - Africa 460
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 18
AN - Antartide 1
Totale 72.347
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 35.760
SG - Singapore 7.420
CN - Cina 4.990
FI - Finlandia 2.585
BR - Brasile 2.344
VN - Vietnam 2.336
DE - Germania 2.090
IT - Italia 1.860
UA - Ucraina 1.761
HK - Hong Kong 1.560
TR - Turchia 1.138
GB - Regno Unito 1.054
FR - Francia 623
PL - Polonia 563
JP - Giappone 531
SE - Svezia 500
RU - Federazione Russa 499
BD - Bangladesh 418
IN - India 380
CA - Canada 373
MX - Messico 316
ID - Indonesia 257
AR - Argentina 237
ZA - Sudafrica 170
NL - Olanda 163
IQ - Iraq 141
ES - Italia 134
BE - Belgio 106
EC - Ecuador 103
PK - Pakistan 93
CO - Colombia 89
VE - Venezuela 80
UZ - Uzbekistan 72
MY - Malesia 67
CZ - Repubblica Ceca 64
MA - Marocco 63
AT - Austria 61
LT - Lituania 59
SA - Arabia Saudita 57
CL - Cile 54
PH - Filippine 53
KE - Kenya 51
IR - Iran 40
PY - Paraguay 37
CH - Svizzera 35
PE - Perù 35
JO - Giordania 34
TN - Tunisia 34
AU - Australia 33
AE - Emirati Arabi Uniti 32
IE - Irlanda 32
DZ - Algeria 31
NP - Nepal 31
JM - Giamaica 26
IL - Israele 25
RO - Romania 23
AL - Albania 21
AZ - Azerbaigian 21
KR - Corea 21
UY - Uruguay 21
ET - Etiopia 20
EG - Egitto 19
TH - Thailandia 19
TW - Taiwan 19
CR - Costa Rica 18
GR - Grecia 18
PT - Portogallo 18
KZ - Kazakistan 14
OM - Oman 14
PS - Palestinian Territory 14
BG - Bulgaria 13
SN - Senegal 13
DO - Repubblica Dominicana 12
EU - Europa 12
NO - Norvegia 12
RS - Serbia 12
BO - Bolivia 11
NG - Nigeria 11
GE - Georgia 10
LB - Libano 10
BH - Bahrain 9
KG - Kirghizistan 9
PA - Panama 9
SK - Slovacchia (Repubblica Slovacca) 9
TT - Trinidad e Tobago 9
KW - Kuwait 8
BY - Bielorussia 7
CI - Costa d'Avorio 7
DK - Danimarca 7
HN - Honduras 7
HU - Ungheria 7
NZ - Nuova Zelanda 7
SV - El Salvador 7
BA - Bosnia-Erzegovina 6
GT - Guatemala 6
NI - Nicaragua 6
AF - Afghanistan, Repubblica islamica di 5
AO - Angola 5
BW - Botswana 5
GA - Gabon 5
Totale 72.236
Salva come PNG Salva come JPEG
Città #
Singapore 4.544
Ashburn 3.763
Woodbridge 2.988
Fairfield 2.929
San Jose 2.274
Helsinki 2.130
Chandler 1.929
Houston 1.928
Jacksonville 1.838
Santa Clara 1.615
Hong Kong 1.520
Beijing 1.504
Ann Arbor 1.407
Seattle 1.210
Wilmington 1.114
Cambridge 962
Dallas 960
Ho Chi Minh City 796
New York 702
Izmir 633
Nanjing 572
Los Angeles 547
Warsaw 544
Hanoi 540
Ferrara 527
Munich 519
Tokyo 504
Princeton 437
Boardman 407
Lauterbourg 370
The Dalles 297
San Diego 276
Council Bluffs 258
Milan 243
São Paulo 233
Shanghai 219
Mexico City 208
Orem 191
Dearborn 173
Nanchang 173
Shenyang 171
Jakarta 170
Bremen 162
London 159
Buffalo 157
Tianjin 142
Chicago 133
Hebei 120
Brooklyn 119
Montreal 114
Toronto 113
Hefei 112
Jiaxing 110
Da Nang 106
Frankfurt am Main 105
Falls Church 104
Changsha 101
Denver 100
Turku 99
Brussels 97
Chennai 97
Johannesburg 97
Rome 93
Haiphong 91
Redwood City 86
Jinan 83
Atlanta 81
Moscow 76
Falkenstein 75
Norwalk 74
Rio de Janeiro 74
Phoenix 72
San Mateo 71
Stockholm 70
Amsterdam 69
Kunming 68
Manchester 65
Mountain View 65
Tashkent 64
Guangzhou 63
San Francisco 62
Poplar 60
Belo Horizonte 58
Nuremberg 58
Baghdad 57
Düsseldorf 57
Curitiba 52
Zhengzhou 50
Auburn Hills 49
Biên Hòa 48
Brno 48
Hải Dương 46
Boston 45
Dong Ket 44
Nairobi 44
Des Moines 43
Addison 42
Bologna 42
Brasília 42
Hangzhou 41
Totale 49.000
Salva come PNG Salva come JPEG
Nome #
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 2.046
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System 426
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 348
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 321
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 304
AN EXON-SPECIFIC U1 SMALL NUCLEAR RNA (snRNA) STRATEGY TO CORRECT SPLICING MUTATIONS ASSOCIATED TO HEMOPHILIA B 301
Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides 299
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 299
An exon-specific U1snRNA induces a robust factor IX activity in mice expressing multiple human FIX splicing mutants 294
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 287
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 286
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 279
Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy 279
A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates 263
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V-related disorders 263
Hemostasis biomarkers in multiple sclerosis 257
Characterization of a deleted Y chromosome in a male with Turner stigmata 256
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family 255
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 252
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 251
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 251
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 248
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 248
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 247
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 247
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 246
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 246
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 246
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 243
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 242
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 241
Attività sulla emostasi di alcune piante della medicina tradizionale indiana 241
Chronic sleep deprivation markedly reduces coagulation factor VII expression 241
Analisi dei multimeri del fattore von Willebrand mediante doppia immunoprecipitazione dopo elettroforesi su gel di agarosio. 241
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 241
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype 240
Membrane binding and anticoagulant properties of protein S natural variants 238
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 238
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 237
High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus? 237
Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant 237
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 233
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 232
A NEW DISEASE-CAUSING MUTATION IN THE GAP-RELATED DOMAIN OF THE NF1 GENE 230
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 228
Moderate alcohol intake and hemostatic and inflammatory markers in middle-aged women: a controlled study 228
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 226
Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity 225
Evidence for an overlapping role of clock and npas2 transcription factors in liver circadian oscillators 224
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 221
c-myc oncogene alterations in human thyroid carcinomas. 221
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects 220
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 220
A missense mutation (Y1702C) in the coagulation factor V gene is a frequent cause of factor V deficiency in the italian population 217
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 217
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 216
A unique exon specific U1snRNA rescues different haemophilia B - causing splicing-defective factor IX variants in mice 216
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 215
Psychiatric disorder in a familial 15;18 translocation and sublocalization of myelin basic protein of 18q22.3 214
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 213
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 213
TRATTAMENTO E PREVENZIONE DI MALATTIE CARDIOVASCOLARI CON ACIDO ERUCICO E METODI DIAGNOSTICI CORRELATI 213
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 212
The factor V Glu1608Lys mutation is recurrent in familial thrombophilia 211
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 210
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 210
Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis 208
A new factor V gene polymorphism (His 1254 Arg) present in subjects of African origin mimics the R2 polymorphism (His 1299 Arg) 208
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 208
The dominant-negative von Willebrand factor gene deletion p.P1127-C1948delinsR: Molecular mechanism and modulation 208
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 208
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 207
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 207
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 207
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 204
Acute Coronaric Syndroms and FVII polymorphisms: different effects in the same gene 204
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects 203
Aberrant splicing reverts a potentially lethal coagulation deficiency caused by a +1g/t splicing mutation 203
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 202
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 201
The carboxyl-terminal region of human coagulation factor X as a novel naturally-occuring linker for fusion strategies 201
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 199
A novel factor V null mutation detected in a thrombophilic patient with pseudo-homozygous APC resistance and in an asymptomatic unrelated subject 199
Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma 199
Ribosome readthrough accounts for secreted full-length factor IX in hemophilia B patients with nonsense mutations 198
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 198
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 197
Correction of aberrant splicing causing haemophilia B through the combination of compensatory U1snRNAs and antisense oligonucleotides 197
Performance prediction models based on anthropometric, genetic and psychological traits of Croatian sprinters 197
Plasma levels of soluble NCAM in multiple sclerosis 196
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 195
The complete impairment of factor VII gene expression by the IVS6+1g/t mutation is compatible with a severe but not lethal bleeding disorder 195
Circadian rhythms in mouse blood coagulation 194
Temporal variations of coagulation factor VII activity in mice are influenced by lighting regime 194
Factor VII mutant V154G models a zymogen-like form of factor VIIa 193
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 193
Variation of factor VII 140s and 170s loops in fishes: evolutionary aspects and comparison with mutations found in FVII deficiency 193
Residual factor VII activity and different hemorrhagic phenotypes in CRM+ factor VII deficiencies (Gly331Ser and Gly283Ser) 193
A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide 192
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 192
Totale 24.940
Salva come PNG Salva come JPEG
Categoria #
all - tutte 313.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.047
Totale 315.565
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021291 0 0 0 0 0 0 0 0 0 0 0 291
2021/20224.434 245 482 276 246 261 178 206 211 138 344 391 1.456
2022/20234.440 488 342 109 583 726 661 211 356 543 39 244 138
2023/20242.348 203 277 110 81 166 433 65 154 59 56 64 680
2024/20259.468 266 186 817 272 1.175 920 242 468 1.492 1.197 1.356 1.077
2025/202629.324 2.588 1.191 2.610 3.726 4.020 1.831 3.329 1.476 4.398 2.817 1.231 107
Totale 73.062